These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 2588959)
1. Fibrinogen Sapporo: dysfibrinogenemia characterized by the replacement of A alpha arginine-16 by histidine resulting in the delayed release of fibrinopeptide A by thrombin. Asakura S; Terukina S; Yamazumi K; Matsuda M; Murayama H; Higuchi A; Musashi M; Sakurada K; Miyazaki T Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1094-104. PubMed ID: 2588959 [TBL] [Abstract][Full Text] [Related]
2. Fibrinogen Kawaguchi: an abnormal fibrinogen characterized by defective release of fibrinopeptide A. Matsuda M; Saeki E; Kasamatsu A; Nakamikawa C; Manabe S; Samejima Y Thromb Res; 1985 Feb; 37(3):379-90. PubMed ID: 3992527 [TBL] [Abstract][Full Text] [Related]
3. Fibrinogen Milano IV, another case of congenital dysfibrinogenemia with an abnormal fibrinopeptide A release (A alpha 16 Arg----His). Bögli C; Hofer A; Baudo F; Redaelli R; Furlan M Haemostasis; 1992; 22(1):7-11. PubMed ID: 1521828 [TBL] [Abstract][Full Text] [Related]
4. [Fibrinogen Bern III: a further case of hereditary fibrinogen variants with substitution A alpha 16 Arg----Cys]. Furlan M; Leupin L; Biasiutti FD; Lämmle B Schweiz Med Wochenschr; 1991 Jul; 121(29):1068-71. PubMed ID: 1891701 [TBL] [Abstract][Full Text] [Related]
5. Fibrinogen Seattle II: congenital dysfibrinogenemia with an Arg (A alpha 16)----his substitution. Ebert RF; Schreiler WE; Bell WR Thromb Res; 1986 Jul; 43(1):7-13. PubMed ID: 3726812 [TBL] [Abstract][Full Text] [Related]
6. Fibrinogen Barcelona II: a new case of A alpha 16 Arg----His substitution. Borrell M; Vila L; Solá J; Coll I; Fontcuberta J Haemostasis; 1990; 20(1):1-7. PubMed ID: 2323678 [TBL] [Abstract][Full Text] [Related]
7. [Fibrinogen Bern II: hereditary fibrinogen variant with amino acid substitution of arginine replaced by histidine in position 16 of the A alpha chain]. Rupp C; Sievi R; Furlan M; Beck EA Schweiz Med Wochenschr; 1983 Oct; 113(40):1460-2. PubMed ID: 6648427 [TBL] [Abstract][Full Text] [Related]
8. Fibrinogen Milano. VI: A heterozygous dysfibrinogenemia (A alpha 16 Arg----His) with bleeding tendency. Bögli C; Cofrancesco E; Cortellaro M; Della Volpe A; Hofer A; Furlan M; Zanussi C Eur J Haematol; 1990 Jul; 45(1):26-30. PubMed ID: 2379562 [TBL] [Abstract][Full Text] [Related]
9. Novel structure elucidation strategy for genetically abnormal fibrinogens with incomplete fibrinopeptide release as applied to fibrinogen Schwarzach. Henschen A; Kehl M; Deutsch E Hoppe Seylers Z Physiol Chem; 1983 Dec; 364(12):1747-51. PubMed ID: 6667926 [TBL] [Abstract][Full Text] [Related]
10. Fibrinogen Kiel: a congenital dysfibrinogenaemia with (A alpha-16 Arg----His) substitution characterized by HPLC without prior isolation of fibrinogen. Seydewitz HH; Gram J; Bruhn HD; Witt I Blood Coagul Fibrinolysis; 1991 Aug; 2(4):501-6. PubMed ID: 1768762 [TBL] [Abstract][Full Text] [Related]
11. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions. Soya K; Terasawa F; Okumura N Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100 [TBL] [Abstract][Full Text] [Related]
12. Heterozygous abnormal fibrinogen Osaka III with the replacement of gamma arginine-275 by histidine has an apparently higher molecular weight gamma-chain variant. Yoshida N; Imaoka S; Hirata H; Matsuda M; Asakura S Thromb Haemost; 1992 Nov; 68(5):534-8. PubMed ID: 1455400 [TBL] [Abstract][Full Text] [Related]
13. Fibrinogen Osaka IV: a congenital dysfibrinogenemia found in a patient originally reported in relation to surgery, now defined to have an A alpha arginine-16 to histidine substitution. Yamazumi K; Terukina S; Matsuda M; Kanbayashi J; Sakon M; Tsujinaka T Surg Today; 1993; 23(1):45-50. PubMed ID: 8461606 [TBL] [Abstract][Full Text] [Related]
14. Fibrinogen Magdeburg I: a novel variant of human fibrinogen with an amino acid exchange in the fibrinopeptide A (Aalpha 9, Leu-->Pro). Meyer M; Kutscher G; Stürzebecher J; Riesener G; Lutze G Thromb Res; 2003 Jan; 109(2-3):145-51. PubMed ID: 12706644 [TBL] [Abstract][Full Text] [Related]
15. Fibrinogen New Orleans: hereditary dysfibrinogenemia with an A alpha chain abnormality. Andes WA; Chavin SI; Beltran G; Stuckey WJ Thromb Res; 1982 Jan 1-15; 25(1-2):41-50. PubMed ID: 6801812 [TBL] [Abstract][Full Text] [Related]
16. Thrombin-induced fibrinopeptide release from a fibrinogen variant (fibrinogen Sydney I) with an Aalpha Arg-16----His substitution. Southan C; Lane DA; Bode W; Henschen A Eur J Biochem; 1985 Mar; 147(3):593-600. PubMed ID: 3979390 [TBL] [Abstract][Full Text] [Related]
17. ["Fibrinogen Kawaguchi": a hereditary dysfibrinogenemia characterized by defective release of fibrinopeptide A associated with altered polymerization of fibrin monomers]. Saeki E; Matsuda M; Ichinose A; Samejima Y; Kasamatsu A; Ara R; Mitsuno K; Kihara T; Hara Y Nihon Ketsueki Gakkai Zasshi; 1985 Aug; 48(5):1229-35. PubMed ID: 4072586 [No Abstract] [Full Text] [Related]
18. Fibrinogen Guarenas I: partial characterization of a new dysfibrinogenemia with an altered rate of fibrinopeptide release and an impaired polymerization. Lundberg UG; Rodriguez S; Marchi R; Ruiz-Saez A; Arocha-Piñango CL Thromb Res; 1995 Apr; 78(2):95-106. PubMed ID: 7482436 [TBL] [Abstract][Full Text] [Related]
19. A new congenital abnormal fibrinogen Ise characterized by the replacement of B beta glycine-15 by cysteine. Yoshida N; Wada H; Morita K; Hirata H; Matsuda M; Yamazumi K; Asakura S; Shirakawa S Blood; 1991 May; 77(9):1958-63. PubMed ID: 2018836 [TBL] [Abstract][Full Text] [Related]
20. Fibrinogen Šumperk II: dysfibrinogenemia in an individual with two coding mutations. Kotlín R; Suttnar J; Cápová I; Hrachovinová I; Urbánková M; Dyr JE Am J Hematol; 2012 May; 87(5):555-7. PubMed ID: 22407772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]